Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation
William J. Metzler(Bristol-Myers Squibb (United States)), Jovita Marcinkeviciene(Bristol-Myers Squibb (United States)), James Tamura(Bristol-Myers Squibb (United States)), Yaqun Zhang(Peking University), Martin J. Corbett(Bristol-Myers Squibb (United States)), Joseph Yanchunas(Bristol-Myers Squibb (United States)), Bin He(Guiyang Medical University), Kevin Kish(Bristol-Myers Squibb (United States)), Carolyn A. Weigelt(Bristol-Myers Squibb (United States)), Dianlin Xie(Bristol-Myers Squibb (United States)), Mark Kirby(Bristol-Myers Squibb (United States)), Herbert E. Klei(Bristol-Myers Squibb (United States)), Lawrence G. Hamann(Ligand Pharmaceuticals (United States))
Cited by 128
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|936
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306